The Canadian Public Drug Claims Database is an essential tool for market access managers to:
Develop Budget Impact Analyses (BIA) for public pharmaceutical reimbursement submissions
Prepare for negotiations with the Pan Canadian Pharmaceutical Alliance (PCPA)
Develop Environmental Scans on competitors and various therapeutic areas
The database is a subscription-based online service offering numerous benefits not available with other providers, such as:
Cost Effectiveness – The Canadian Drug Claims Database allows company-wide access to the database with one subscription.
Timely and Accurate Data – Quarterly claims data is sourced directly from provincial drug plans and the NIHB. BIA’s based on PDCI’s Canadian Public Drug Claims Database contain data that is verifiable by provincial payers. Our data is not extrapolated from other sources and there is no need to adjust outputs for capture rates.
Program definitions – We provide a clear definition of the programs reported to PDCI by the provinces. Where possible the claims data is reported by program, to enable enhanced understanding of provincial claims and market segmentation.
Easy to Use Interface – The Database features a newly redesigned user-friendly interface including online reporting tools and can be easily exported to Excel or csv files.
Ask about our capabilities to analyze and explore deidentified patient level claims data to characterize product specific reimbursement journeys.
For more information regarding our Canadian Public Drug Claims Database and Patient Level Claims Data, please contact the PDCI Data Team.
